Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis.

Published in: European journal of clinical pharmacology (2021)

Close observation can be considered for COVID-19 patients who use PPIs to prevent severe outcomes. However, caution should be taken because of substantial heterogeneity and plausible protopathic bias.

Keyphrases

coronavirus disease
sars cov
early onset
risk factors
single cell
respiratory syndrome coronavirus
type diabetes
skeletal muscle
weight loss